1030882-65-5

Basic information

• Product Name: tert-butyl 2-(2-oxoiMidazolidin-1-yl)acetate
• Synonyms: tert-butyl 2-(2-oxoiMidazolidin-1-yl)acetate
• CAS NO: 1030882-65-5
• Molecular Formula: C9H16N2O3
• Molecular Weight: 200.23494
• EINECS: -0
• Mol File: 1030882-65-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 2-(2-oxoiMidazolidin-1-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-(2-oxoiMidazolidin-1-yl)acetate(1030882-65-5)
• EPA Substance Registry System: tert-butyl 2-(2-oxoiMidazolidin-1-yl)acetate(1030882-65-5)

Safety Data

• Hazardous Substances Data: 1030882-65-5(Hazardous Substances Data)

Upstream product

• 120-93-4 imidazolidone 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 1220972-38-2 2-(3-(4-octylbenzyl)-2-oxoimidazolidin-1-yl)acetic acid 

Downstream Products

• 1220972-39-3 tert-butyl 2-(3-(4-octylbenzyl)-2-oxoimidazolidin-1-yl)acetate 

Relevant articles and documents

S1P RECEPTORS MODULATORS AND THEIR USE THEREOF

The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.

2-ARYLTHIAZOLE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS

The invention encompasses compounds of Formula I or pharmaceutically acceptable salts thereof, which are modulators of the CXCR3 chemokine receptor function useful for the treatment or prevention of pathogenic inflammatory processes, autoimmune diseases or graft rejection processes. Methods of use and pharmaceutical compositions are also encompassed.